Skip to Content

DF 15 (Darifenacin Hydrobromide Extended Release 15 mg)

Pill with imprint DF 15 is Orange, Round and has been identified as Darifenacin Hydrobromide Extended Release 15 mg. It is supplied by Actavis Pharma, Inc..

Darifenacin is used in the treatment of overactive bladder; urinary incontinence; urinary frequency and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DF 15

Darifenacin Hydrobromide Extended Release

DF 15
15 mg
8.00 mm
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromelloses, magnesium stearate, polyethylene glycol (PEG) 200, magnesium silicate, titanium dioxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-4380 Watson Pharmaceuticals, Inc.
00430-0171 Warner Chilcott
54868-5363 Physicians Total Care Inc. (repackager)
35356-0272 Lake Erie Medical and Surgical Supply (repackager)
68071-1315 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "DF 15"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.